Hussman Strategic Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,000
| Closed | -$683K | – | 220 |
|
|
2024
Q2 | $683K | Hold |
42,000
| – | – | 0.19% | 172 |
|
|
2024
Q1 | $777K | Hold |
42,000
| – | – | 0.18% | 158 |
|
|
2023
Q4 | $1.32M | Hold |
42,000
| – | – | 0.3% | 134 |
|
|
2023
Q3 | $875K | Sell |
42,000
-20,000
| -32% | -$417K | 0.17% | 213 |
|
|
2023
Q2 | $1.48M | Sell |
62,000
-31,000
| -33% | -$742K | 0.27% | 168 |
|
|
2023
Q1 | $1.75M | Buy |
+93,000
| New | +$1.75M | 0.27% | 151 |
|